Status:

ACTIVE_NOT_RECRUITING

MuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart Transplantation (LEONE-HT)

Lead Sponsor:

Juan Francisco Delgado Jimenez

Collaborating Sponsors:

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

Conditions:

Transplant Failure

Heart Transplant Rejection

Eligibility:

All Genders

Brief Summary

Cross-sectional evaluation of antibody mediated injury in heart transplantation patients through a multimodal approach: electron microscopy, optic microscopy, immunohistochemistry techniques, transtho...

Detailed Description

Heart transplant survival has barely improved in the last decades and unsatisfactory for a large proportion of heart transplant recipients. The development of leukocyte antigen antibodies (anti-HLA) i...

Eligibility Criteria

Inclusion

  • Exposed:
  • Heart transplant recipients
  • "De novo" antiHLA detection (after heart transplant):
  • Mean fluorescence intensity (MFI)) \> 2000 for donor-specific antibodies
  • Standard fluorescence intensity (SFI) \> 150 000 for non-donor specific antibodies
  • Detailed immunological history:
  • Determination of anti-HLA antibodies before heart transplant.
  • Serial determination of anti-HLA antibodies during heart transplantation follow-up
  • Known HLA typing of the donor.
  • Non-exposed: Heart transplant procedure contemporary to the index case with negative anti-HLA antibodies.

Exclusion

  • Recipient of a second HT
  • Multiple organ transplantation
  • Unknown immunological history
  • Recipients sensitized with anti-HLA antibodies against donor's HLA before the transplant
  • CMR contrast will not be administered in patients with glomerular filtration rate \< 30 ml/kg/1.73m2
  • Patients with implanted cardiac devices or any other magnetic resonance non-compatible metallic prosthetic material will not undergo CMR.

Key Trial Info

Start Date :

April 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 30 2029

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT05184426

Start Date

April 1 2021

End Date

September 30 2029

Last Update

June 21 2022

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Hospital Universitario Puerta de Hierro Majadahonda

Majadahonda, Madrid, Spain, 28222

2

Hospital General Universitario Gregorio Marañon

Madrid, Spain, 28007

3

Hospital Universitario 12 de Octubre

Madrid, Spain, 28041